0 XP   0   0   0

Tarsus Pharmaceuticals Inc
Buy or Sell?

I guess you are interested in Tarsus Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Tarsus Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Tarsus Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Tarsus Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Tarsus Pharmaceuticals Inc. The closing price on 2022-09-23 was $16.01 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Daily Candlestick Chart

1.1. Profitability of Tarsus Pharmaceuticals Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is -37.6%. The company is losing money. -2
  • The TTM is -2,363.0%. The company is losing money. -2
Trends
Current periodCompared to+/- 
MRQ-37.6%TTM-2,363.0%+2,325.4%
TTM-2,363.0%YOY15.0%-2,378.0%
TTM-2,363.0%5Y-853.8%-1,509.2%
5Y-853.8%10Y-853.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.6%-242.4%+204.8%
TTM-2,363.0%-275.9%-2,087.1%
YOY15.0%-335.9%+350.9%
5Y-853.8%-469.8%-384.0%
10Y-853.8%-549.9%-303.9%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is -2.3%. Very bad. -2
  • The TTM is -2,080.7%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2,080.7%+2,078.4%
TTM-2,080.7%YOY-2.3%-2,078.4%
TTM-2,080.7%5Y-758.5%-1,322.2%
5Y-758.5%10Y-758.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%-9.8%+7.5%
TTM-2,080.7%-8.8%-2,071.9%
YOY-2.3%-9.2%+6.9%
5Y-758.5%-11.6%-746.9%
10Y-758.5%-12.7%-745.8%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is -2.6%. Very bad. -2
  • The TTM is -2,233.0%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2,233.0%+2,230.4%
TTM-2,233.0%YOY0.5%-2,233.5%
TTM-2,233.0%5Y-812.4%-1,420.6%
5Y-812.4%10Y-812.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-11.9%+9.3%
TTM-2,233.0%-11.2%-2,221.8%
YOY0.5%-10.6%+11.1%
5Y-812.4%-13.7%-798.7%
10Y-812.4%-14.5%-797.9%

1.2. Operating Efficiency of Tarsus Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is -35.8%. Very bad. -2
  • The TTM is -2,380.0%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-35.8%TTM-2,380.0%+2,344.2%
TTM-2,380.0%YOY15.2%-2,395.3%
TTM-2,380.0%5Y-859.9%-1,520.1%
5Y-859.9%10Y-859.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.8%-232.1%+196.3%
TTM-2,380.0%-269.6%-2,110.4%
YOY15.2%-306.8%+322.0%
5Y-859.9%-461.8%-398.1%
10Y-859.9%-546.8%-313.1%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is 1.342. Very good. +2
  • The TTM is 0.604. Very good. +2
Trends
Current periodCompared to+/- 
MRQ1.342TTM0.604+0.738
TTM0.604YOY0.337+0.267
TTM0.6045Y0.342+0.262
5Y0.34210Y0.3420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3423.321-1.979
TTM0.6043.662-3.058
YOY0.3373.692-3.355
5Y0.3425.743-5.401
10Y0.3426.919-6.577

1.3. Liquidity of Tarsus Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is 21.359. Very Good. +2
  • The TTM is 13.400. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ21.359TTM13.400+7.959
TTM13.400YOY21.079-7.679
TTM13.4005Y22.214-8.814
5Y22.21410Y22.2140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.3595.318+16.041
TTM13.4006.219+7.181
YOY21.0796.366+14.713
5Y22.2146.760+15.454
10Y22.2146.520+15.694
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is 20.992. Very good. +2
  • The TTM is 13.178. Very good. +2
Trends
Current periodCompared to+/- 
MRQ20.992TTM13.178+7.814
TTM13.178YOY20.685-7.507
TTM13.1785Y12.318+0.860
5Y12.31810Y12.3180.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9924.107+16.885
TTM13.1784.994+8.184
YOY20.6855.257+15.428
5Y12.3185.338+6.980
10Y12.3185.050+7.268

1.4. Solvency of Tarsus Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is 0.124. Very good. +2
  • The TTM is 0.107. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.107+0.017
TTM0.107YOY0.334-0.227
TTM0.1075Y0.367-0.260
5Y0.36710Y0.3670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1240.269-0.145
TTM0.1070.267-0.160
YOY0.3340.296+0.038
5Y0.3670.362+0.005
10Y0.3670.398-0.031
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is 0.141. Very good. +2
  • The TTM is 0.123. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.141TTM0.123+0.018
TTM0.123YOY0.038+0.086
TTM0.1235Y0.065+0.058
5Y0.06510Y0.0650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1410.305-0.164
TTM0.1230.303-0.180
YOY0.0380.309-0.271
5Y0.0650.382-0.317
10Y0.0650.436-0.371

2. Market Valuation of Tarsus Pharmaceuticals Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tarsus Pharmaceuticals Inc:

  • The EOD is -5.945. Company is losing money. -2
  • The MRQ is -5.421. Company is losing money. -2
  • The TTM is -19.918. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.945MRQ-5.421-0.524
MRQ-5.421TTM-19.918+14.497
TTM-19.918YOY-33.849+13.931
TTM-19.9185Y-19.552-0.367
5Y-19.55210Y-19.5520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.945-2.088-3.857
MRQ-5.421-2.275-3.146
TTM-19.918-3.796-16.122
YOY-33.849-4.994-28.855
5Y-19.552-3.642-15.910
10Y-19.552-3.303-16.249
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Tarsus Pharmaceuticals Inc:

  • The MRQ is -0.009. Very Bad. -2
  • The TTM is 0.337. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.009TTM0.337-0.347
TTM0.3375Y0.3370.000
5Y0.33710Y0.3370.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0090.005-0.014
TTM0.3370.020+0.317
5Y0.3370.021+0.316
10Y0.3370.017+0.320

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tarsus Pharmaceuticals Inc:

  • The EOD is 1.759. Good. +1
  • The MRQ is 1.604. Good. +1
  • The TTM is 697.984. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD1.759MRQ1.604+0.155
MRQ1.604TTM697.984-696.380
TTM697.984YOY2.960+695.024
TTM697.9845Y254.889+443.095
5Y254.88910Y254.8890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.7591.808-0.049
MRQ1.6041.944-0.340
TTM697.9842.750+695.234
YOY2.9603.492-0.532
5Y254.8892.731+252.158
10Y254.8892.401+252.488

2.4. Latest News of Tarsus Pharmaceuticals Inc

Does Tarsus Pharmaceuticals Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Tarsus Pharmaceuticals Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-17
16:23
The Chief Medical Advisor & Director of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), Elizabeth Lin, Just Bought A Few More SharesRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tarsus Pharmaceuticals Inc.

3.1. Institutions holding Tarsus Pharmaceuticals Inc

Institutions are holding 75.246% of the shares of Tarsus Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Vivo Capital, LLC8.67873.39012312368-674963-22.5942
2022-06-30TANG CAPITAL MANAGEMENT LLC7.8234.617720843701784370594.79
2022-03-31RTW INVESTMENTS, LLC7.55740.701201360100
2022-06-30TimesSquare Capital Management, LLC5.56110.30161481710822110124.6377
2022-03-31Cormorant Asset Management, LLC5.16431.77691375982-27349-1.9489
2022-03-31Perceptive Advisors LLC4.86560.43681296416-1296416-50
2022-06-30COWEN AND COMPANY, LLC2.00620.753653452400
2022-03-31Vanguard Group Inc1.7220.0002458816-374-0.0814
2022-03-31Jefferies Group Inc1.51160.0395402758-20235-4.7838
2022-06-30Assenagon Asset Management SA1.35770.01963617413617410
2022-06-30Geode Capital Management, LLC0.99870.0006266084135326103.4935
2022-03-31Sands Capital Ventures, LLC0.97580.913626000000
2022-06-30Ensign Peak Advisors Inc0.910.008424245100
2022-06-30Rubric Capital Management LP0.76060.15542026482026480
2022-03-31State Street Corporation0.49870.000113288331412.421
2022-06-30Ghost Tree Capital, LLC0.45040.912512000000
2022-06-30Alyeska Investment Group, L.P.0.28150.012575000750000
2022-03-31Northern Trust Corp0.2580.000268732-3049-4.2476
2022-06-30SG Americas Securities, LLC0.18960.007950512807319.0226
2022-03-31Charles Schwab Investment Management Inc0.18230.00034858314022.9715
Total 51.753214.048513789179  

3.2. Funds holding Tarsus Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-29iShares Russell 2000 ETF1.40070.01053731963250.0872
2022-07-31Vanguard Total Stock Mkt Idx Inv1.27590.000433994900
2022-03-31Empower Small Cap Growth/TimesSquare SP0.85010.3661226500115005.3488
2022-07-31Vanguard Extended Market Index Investor0.77810.0036207328-12634-5.7437
2022-07-29iShares Russell 2000 Value ETF0.67040.021817861500
2022-06-30Delaware Healthcare I0.6490.29417290800
2022-07-31AMG TimesSquare Small Cap Growth Z0.57520.84515325000
2022-03-31TimesSquare CIT Small Cap Growth A0.39450.34241051001051000
2022-07-31GuideStone Funds Small Cap Equity Instl0.38320.20910210000
2022-07-31State St Russell Sm/Mid Cp® Indx NL Cl C0.28740.0035765863214372.3241
2022-07-31State St Russell Sm Cap® Indx NL Cl C0.24090.01066419000
2022-05-31Fidelity® Small Cap Index0.23180.00456176500
2022-06-30Fidelity® Extended Market Index0.23130.00316161531123102.0694
2022-06-30NT R2000 Value Index Fund - NL0.21350.02325688051561969.3739
2022-06-30NT R2000 Index Fund - NL0.19490.01165192827017108.4541
2022-07-29Schwab US Small-Cap ETF™0.17260.0054599700
2022-07-31Vanguard Russell 2000 ETF0.1650.010843969-1094-2.4277
2022-06-30DFA US Small Cap I0.1550.0046412971274644.6429
2022-07-31Schwab Small Cap Index0.15350.0114089810682.6814
2022-06-30NT R2000 Index Fund - DC - NL - 20.1440.01173835719931108.1678
Total 9.1672.19242442428  

3.3. Insider Transactions

Insiders are holding 13.253% of the shares of Tarsus Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-18Leonard M GreensteinSELL500016.364289
2022-08-17Bobak R AzamianSELL800016.591196106
2022-05-05Michael AckermannBUY10000013.5100000
2022-05-04Vivo Capital Ix, LlcSELL1973812.672474375
2022-05-02Vivo Capital Ix, LlcSELL4180015.192945531
2021-12-01Michael AckermannSELL583324.68
2021-11-08Aziz MottiwalaSELL188928.11
2021-11-04Aziz MottiwalaSELL10028.03
2021-11-02Aziz MottiwalaSELL600026.78
2021-11-01Michael AckermannSELL583327.82
2021-10-12Bobak R AzamianSELL553126.3
2021-10-12Michael AckermannSELL563326.27
2021-10-08Bobak R AzamianSELL30225.02
2021-10-08Michael AckermannSELL20025.03
2021-09-10Aziz MottiwalaSELL259322.1558203
2021-09-01Michael AckermannSELL583325.241221515
2021-08-11Bobak R. AzamianSELL191725.071750
2021-08-11Michael AckermannSELL62125.151227348
2021-08-09Bobak R AzamianSELL82725.021750
2021-08-09Michael AckermannSELL70025

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Tarsus Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--9.1036.249+46%6.254+46%4.883+86%4.883+86%
Current Ratio--21.35913.400+59%21.079+1%22.214-4%22.214-4%
Debt To Asset Ratio--0.1240.107+16%0.334-63%0.367-66%0.367-66%
Debt To Equity Ratio--0.1410.123+15%0.038+273%0.065+116%0.065+116%
Eps---0.236-0.673+185%-0.098-59%-0.327+39%-0.327+39%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.376-23.630+6186%0.150-351%-8.538+2171%-8.538+2171%
Operating Margin---0.358-23.800+6546%0.152-335%-8.599+2301%-8.599+2301%
Operating Ratio--1.3420.604+122%0.337+298%0.342+292%0.342+292%
Pb Ratio1.759+9%1.604697.984-100%2.960-46%254.889-99%254.889-99%
Pe Ratio-5.945-10%-5.421-19.918+267%-33.849+524%-19.552+261%-19.552+261%
Peg Ratio---0.0090.337-103%--0.337-103%0.337-103%
Price Per Share16.010+9%14.60018.868-23%25.635-43%16.183-10%16.183-10%
Quick Ratio--20.99213.178+59%20.685+1%12.318+70%12.318+70%
Return On Assets---0.023-20.807+91498%-0.023+2%-7.585+33292%-7.585+33292%
Return On Equity---0.026-22.330+86027%0.005-606%-8.124+31234%-8.124+31234%
 EOD+1 -2MRQTTM+11 -4YOY+7 -75Y+11 -410Y+11 -4

4.2. Fundamental Score

Let's check the fundamental score of Tarsus Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.945
Price to Book Ratio (EOD)Between0-11.759
Net Profit Margin (MRQ)Greater than0-0.376
Operating Margin (MRQ)Greater than0-0.358
Quick Ratio (MRQ)Greater than120.992
Current Ratio (MRQ)Greater than121.359
Debt To Asset Ratio (MRQ)Less than10.124
Debt to Equity Ratio (MRQ)Less than10.141
Return On Equity (MRQ)Greater than0.15-0.026
Return on Assets (MRQ)Greater than0.05-0.023
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Tarsus Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.100
Ma 20Greater thanMa 5015.664
Ma 50Greater thanMa 10015.939
Ma 100Greater thanMa 20014.854
OpenGreater thanClose15.980
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets252,828
Total Liabilities31,323
Total Stockholder Equity221,505
 As reported
Total Liabilities 31,323
Total Stockholder Equity+ 221,505
Total Assets = 252,828

Assets

Total Assets252,828
Total Current Assets250,283
Long-term Assets250,283
Total Current Assets
Cash And Cash Equivalents 245,363
Net Receivables 620
Other Current Assets 4,300
Total Current Assets  (as reported)250,283
Total Current Assets  (calculated)250,283
+/-0
Long-term Assets
Property Plant Equipment 1,776
Long Term Investments 169
Other Assets 600
Long-term Assets  (as reported)2,545
Long-term Assets  (calculated)2,545
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,718
Long-term Liabilities19,605
Total Stockholder Equity221,505
Total Current Liabilities
Short-term Debt 605
Accounts payable 4,093
Other Current Liabilities 7,020
Total Current Liabilities  (as reported)11,718
Total Current Liabilities  (calculated)11,718
+/-0
Long-term Liabilities
Long term Debt 19,262
Capital Lease Obligations Min Short Term Debt300
Other Liabilities 43
Long-term Liabilities  (as reported)19,605
Long-term Liabilities  (calculated)19,605
+/-0
Total Stockholder Equity
Common Stock5
Retained Earnings -72,653
Capital Surplus 294,153
Total Stockholder Equity (as reported)221,505
Total Stockholder Equity (calculated)221,505
+/-0
Other
Capital Stock5
Cash and Short Term Investments 245,363
Common Stock Shares Outstanding 24,333
Common Stock Total Equity5
Liabilities and Stockholders Equity 252,828
Net Debt -225,196
Net Invested Capital 240,767
Net Tangible Assets 221,505
Net Working Capital 238,565
Short Long Term Debt Total 20,167



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-12-31
> Total Assets 
0
0
0
0
0
0
0
58,316
0
56,239
92,185
171,203
193,954
203,450
190,412
179
181,483
252,828
252,828181,483179190,412203,450193,954171,20392,18556,239058,3160000000
   > Total Current Assets 
0
0
0
0
0
0
58,030
58,030
54,706
54,706
89,072
170,655
191,451
200,904
187,088
176
178,755
250,283
250,283178,755176187,088200,904191,451170,65589,07254,70654,70658,03058,030000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
57,952
0
53,135
86,329
168,129
156,179
176,735
183,801
171
175,010
245,363
245,363175,010171183,801176,735156,179168,12986,32953,135057,9520000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
291
0
02910000000000000000
       Net Receivables 
0
0
0
0
0
0
36
36
2
2
1
20
32,446
20,157
139
92
323
620
6203239213920,15732,446201223636000000
       Other Current Assets 
0
0
0
0
0
0
20
20
1,077
1,077
2,742
2,526
2,826
4,012
3,148
-88
3,131
4,300
4,3003,131-883,1484,0122,8262,5262,7421,0771,0772020000000
   > Long-term Assets 
0
0
0
0
0
0
0
286
0
1,533
3,113
548
2,503
2,546
3,324
3
2,728
2,545
2,5452,72833,3242,5462,5035483,1131,53302860000000
       Property Plant Equipment 
0
0
0
0
0
0
280
280
1,395
1,395
1,363
548
1,173
1,021
1,709
1,829
1,841
1,776
1,7761,8411,8291,7091,0211,1735481,3631,3951,395280280000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169
16900000000000000000
       Other Assets 
0
0
0
0
0
0
6
6
138
138
1,750
769
1,330
1,525
1,615
179
887
600
6008871791,6151,5251,3307691,75013813866000000
> Total Liabilities 
0
0
0
0
0
0
0
64,321
0
3,872
110,014
5,992
10,722
10,979
11,270
12
32,286
31,323
31,32332,2861211,27010,97910,7225,992110,0143,872064,3210000000
   > Total Current Liabilities 
0
0
0
0
0
0
819
819
3,075
3,075
6,144
5,387
10,118
10,455
10,365
11,478
12,610
11,718
11,71812,61011,47810,36510,45510,1185,3876,1443,0753,075819819000000
       Short-term Debt 
0
0
0
0
0
0
0
64
0
111
190
282
221
1,733
1,572
0
809
605
60580901,5721,7332212821901110640000000
       Accounts payable 
0
0
0
0
0
0
456
456
1,420
1,420
4,706
4,347
4,997
3,303
2,010
11,478
4,028
4,093
4,0934,02811,4782,0103,3034,9974,3474,7061,4201,420456456000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
1,248
758
4,900
5,419
6,783
11,478
7,773
7,020
7,0207,77311,4786,7835,4194,9007581,2480000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
63,502
0
797
103,870
605
604
524
905
699
19,676
19,605
19,60519,676699905524604605103,870797063,5020000000
       Other Liabilities 
0
0
0
0
0
0
0
0
53
53
86
56
148
524
150
114
71
43
43711141505241485686535300000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
100
100
1,700
0
0
0
0
0
0
0
00000001,70010010000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
-6,005
0
52,367
-17,829
165,980
183,232
192,471
179,142
167
149,197
221,505
221,505149,197167179,142192,471183,232165,980-17,82952,3670-6,0050000000
   Common Stock
0
0
0
0
0
0
2
2
2
2
2
4
4
4
4
0
4
5
540444422222000000
   Retained Earnings Total Equity-72,653-66,910-46,672-31,821-16,124-22,469-32,84500000000000
   Accumulated Other Comprehensive Income 0000-266-1420-93-700-380000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
198,821
205,697
208,591
210,959
213,398
216,103
294,153
294,153216,103213,398210,959208,591205,697198,82100000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
3,641
165,976
205,839
208,857
211
213
216,103
294,153
294,153216,103213211208,857205,839165,9763,6410000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue57,027
Cost of Revenue-2
Gross Profit57,02757,025
 
Operating Income (+$)
Gross Profit57,027
Operating Expense-69
Operating Income-12,15756,958
 
Operating Expense (+$)
Research Development42
Selling General Administrative25
Selling And Marketing Expenses-
Operating Expense6967
 
Net Interest Income (+$)
Interest Income36
Interest Expense--36
Net Interest Income3672
 
Pretax Income (+$)
Operating Income-12,157
Net Interest Income36
Other Non-Operating Income Expenses-1,651
Income Before Tax (EBT)-12-24,302
EBIT - interestExpense = -13,772
-12
-48
Interest Expense-36
Earnings Before Interest and Taxes (ebit)-13,808-48
Earnings Before Interest and Taxes (ebitda)-12
 
After tax Income (+$)
Income Before Tax-12
Tax Provision-55
Net Income From Continuing Ops-13,827-67
Net Income-12
Net Income Applicable To Common Shares-13,827
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses69,184
Total Other Income/Expenses Net12,1451,615
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DAAPL.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAAPL.CC.

DAAPL.CC Daily Candlestick Chart
UIP.CC
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of UIP.CC.

UIP.CC Daily Candlestick Chart
TRC.CC
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRC.CC.

TRC.CC Daily Candlestick Chart
TIX.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIX.CC.

TIX.CC Daily Candlestick Chart
THC.CC
2 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TERC.CC
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
TBTC.CC
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TBTC.CC.

TBTC.CC Daily Candlestick Chart
SWACE.CC
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SWACE.CC.

SWACE.CC Daily Candlestick Chart
START.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of START.CC.

START.CC Daily Candlestick Chart
SNC.CC
2 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SAVG.CC
2 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SAVG.CC.

SAVG.CC Daily Candlestick Chart
RPZX.CC
2 hours ago

I found you a Golden Cross on the daily chart of RPZX.CC.

RPZX.CC Daily Candlestick Chart
RIO.CC
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RIO.CC.

RIO.CC Daily Candlestick Chart
PYRK.CC
2 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRK.CC.

PYRK.CC Daily Candlestick Chart
PLAY.CC
2 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
pBTC35A.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of pBTC35A.CC.

pBTC35A.CC Daily Candlestick Chart
PBTC.CC
2 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PBTC.CC.

PBTC.CC Daily Candlestick Chart
PASC.CC
2 hours ago

I found you a Golden Cross on the daily chart of PASC.CC.

PASC.CC Daily Candlestick Chart
OPCT.CC
2 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
NCDT.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NCDT.CC.

NCDT.CC Daily Candlestick Chart
MSWAP.CC
3 hours ago

I found you a Death Cross on the daily chart of MSWAP.CC.

MSWAP.CC Daily Candlestick Chart
MERI.CC
3 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MERI.CC.

MERI.CC Daily Candlestick Chart
MBC.CC
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBC.CC.

MBC.CC Daily Candlestick Chart